Pacific Shuanglin Bio pharmacy Co Ltd (000403) — Financial Flexibility Index
Pacific Shuanglin Bio pharmacy Co Ltd (000403) has a Financial Flexibility Index of 0.09x as of September 2025. Free cash flow of CN¥142.45 Million (operating CF CN¥70.28 Million minus capex CN¥72.17 Million) represents 0% of total liabilities (CN¥1.55 Billion). Also explore Pacific Shuanglin Bio pharmacy Co Ltd net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Pacific Shuanglin Bio pharmacy Co Ltd Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for Pacific Shuanglin Bio pharmacy Co Ltd across 28 annual periods. Check how strategically is Pacific Shuanglin Bio pharmacy Co Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Pacific Shuanglin Bio pharmacy Co Ltd (1998–2025)
Year-by-year free cash flow to debt coverage for Pacific Shuanglin Bio pharmacy Co Ltd. For the full company profile including market capitalisation, see Pacific Shuanglin Bio pharmacy Co Ltd stock valuation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.08x | CN¥117.41 Million | CN¥-215.99 Million | CN¥1.39 Billion | ▼ -86.6% |
| 2024 | 0.63x | CN¥842.50 Million | CN¥321.79 Million | CN¥1.33 Billion | ▼ -27.5% |
| 2023 | 0.87x | CN¥1.06 Billion | CN¥679.01 Million | CN¥1.21 Billion | ▲ +8.5% |
| 2022 | 0.81x | CN¥902.86 Million | CN¥524.22 Million | CN¥1.12 Billion | ▼ -16.7% |
| 2021 | 0.97x | CN¥734.38 Million | CN¥408.22 Million | CN¥760.07 Million | ▲ +181.9% |
| 2020 | 0.34x | CN¥235.02 Million | CN¥194.84 Million | CN¥685.71 Million | ▼ -30.5% |
| 2019 | 0.49x | CN¥231.96 Million | CN¥190.84 Million | CN¥470.04 Million | ▲ +127.2% |
| 2018 | 0.22x | CN¥151.65 Million | CN¥116.63 Million | CN¥698.08 Million | ▲ +4079.0% |
| 2017 | 0.01x | CN¥3.96 Million | CN¥-35.91 Million | CN¥761.70 Million | ▼ -97.7% |
| 2016 | 0.23x | CN¥160.52 Million | CN¥62.49 Million | CN¥696.41 Million | ▲ +31.5% |
| 2015 | 0.18x | CN¥129.70 Million | CN¥70.31 Million | CN¥739.82 Million | ▼ -13.0% |
| 2014 | 0.20x | CN¥148.09 Million | CN¥77.04 Million | CN¥735.16 Million | ▼ -33.7% |
| 2013 | 0.30x | CN¥254.00 Million | CN¥91.01 Million | CN¥835.47 Million | ▼ -21.8% |
| 2012 | 0.39x | CN¥303.53 Million | CN¥123.24 Million | CN¥780.27 Million | ▲ +29.5% |
| 2011 | 0.30x | CN¥203.72 Million | CN¥130.14 Million | CN¥678.06 Million | ▲ +322.4% |
| 2010 | 0.07x | CN¥46.34 Million | CN¥9.88 Million | CN¥651.42 Million | ▼ -56.5% |
| 2009 | 0.16x | CN¥182.16 Million | CN¥111.86 Million | CN¥1.11 Billion | ▲ +43.2% |
| 2008 | 0.11x | CN¥118.49 Million | CN¥74.90 Million | CN¥1.04 Billion | ▲ +85.9% |
| 2007 | 0.06x | CN¥101.34 Million | CN¥95.03 Million | CN¥1.65 Billion | ▲ +3801.9% |
| 2006 | 0.00x | CN¥-2.88 Million | CN¥-10.42 Million | CN¥1.73 Billion | ▼ -105.8% |
| 2005 | 0.03x | CN¥56.01 Million | CN¥49.06 Million | CN¥1.97 Billion | ▲ +216.0% |
| 2004 | -0.02x | CN¥-37.09 Million | CN¥-131.73 Million | CN¥1.51 Billion | ▼ -132.8% |
| 2003 | 0.07x | CN¥104.70 Million | CN¥-49.47 Million | CN¥1.40 Billion | ▼ -77.0% |
| 2002 | 0.32x | CN¥248.27 Million | CN¥159.18 Million | CN¥765.52 Million | ▲ +12.4% |
| 2001 | 0.29x | CN¥199.24 Million | CN¥111.28 Million | CN¥690.82 Million | ▲ +98.9% |
| 2000 | 0.14x | CN¥83.98 Million | CN¥27.36 Million | CN¥579.29 Million | ▲ +9.6% |
| 1999 | 0.13x | CN¥63.35 Million | CN¥-23.08 Million | CN¥478.92 Million | ▲ +344.3% |
| 1998 | 0.03x | CN¥8.58 Million | CN¥-2.65 Million | CN¥288.28 Million | — |